Post-Lipitor Pfizer Will Have Two Business Models: Innovation And Value
By
Jessica Merrill / Email the Author / “The Pink Sheet” DAILY Jan. 31, 2012
Word Count: 831 / Article # 14120131005
Executive Summary
Pfizer CEO Ian Read provided Wall Street with more clarity on his vision for the company as it moves beyond Lipitor into a new era. Pfizer will have two primary businesses, he said, an innovative pharmaceutical engine and a value business.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.